Israel Englander Ani Pharmaceuticals Inc Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Millennium Management LLC holds 230,079 shares of ANIP stock, worth $13.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

230,079

Previous 20,807 1005.78%

Holding current value

$13.4 Million

Previous $1.44 Million 918.85%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$58.53 - $68.82 $12.2 Million - $14.4 Million	209,272 Added 1005.78%	230,079 $14.7 Million
Q1 2024 May 15, 2024	SELL	$54.2 - $69.69 $80,920 - $104,047	-1,493 Reduced 6.7%	20,807 $1.44 Million
Q4 2023 Feb 14, 2024	BUY	$48.72 - $65.43 $603,835 - $810,939	12,394 Added 125.12%	22,300 $1.23 Million
Q2 2023 Aug 14, 2023	SELL	$37.29 - $53.83 $257,338 - $371,480	-6,901 Reduced 41.06%	9,906 $533,000
Q1 2023 May 15, 2023	SELL	$37.61 - $45.72 $369,593 - $449,290	-9,827 Reduced 36.9%	16,807 $668,000
Q4 2022 Feb 14, 2023	SELL	$31.9 - $41.95 $804,964 - $1.06 Million	-25,234 Reduced 48.65%	26,634 $1.07 Million
Q3 2022 Nov 14, 2022	BUY	$29.83 - $38.01 $433,549 - $552,437	14,534 Added 38.93%	51,868 $1.67 Million
Q2 2022 Aug 15, 2022	SELL	$23.09 - $33.46 $1.06 Million - $1.54 Million	-45,936 Reduced 55.17%	37,334 $1.11 Million
Q1 2022 May 16, 2022	BUY	$26.91 - $47.15 $2.24 Million - $3.93 Million	83,270 New	83,270 $2.34 Million
Q4 2021 Feb 14, 2022	SELL	$32.97 - $56.85 $233,295 - $402,270	-7,076 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.48 - $35.99 $187,372 - $254,665	7,076 New	7,076 $232,000
Q1 2021 May 17, 2021	SELL	$28.4 - $36.14 $657,516 - $836,713	-23,152 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$23.69 - $31.47 $548,470 - $728,593	23,152 New	23,152 $672,000
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $517,938 - $866,980	-17,305 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$30.35 - $67.14 $525,206 - $1.16 Million	17,305 New	17,305 $705,000
Q2 2019 Aug 14, 2019	SELL	$67.77 - $82.2 $480,150 - $582,387	-7,085 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$45.83 - $70.54 $171,679 - $264,242	-3,746 Reduced 34.59%	7,085 $500,000
Q4 2018 Feb 14, 2019	SELL	$41.17 - $56.44 $92,508 - $126,820	-2,247 Reduced 17.18%	10,831 $488,000
Q3 2018 Nov 14, 2018	BUY	$52.95 - $71.34 $692,480 - $932,984	13,078 New	13,078 $739,000
Q2 2018 Aug 14, 2018	SELL	$56.38 - $68.08 $2.68 Million - $3.24 Million	-47,544 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$56.98 - $72.41 $2.52 Million - $3.21 Million	44,288 Added 1360.2%	47,544 $2.77 Million
Q4 2017 Feb 14, 2018	BUY	$53.3 - $74.56 $173,544 - $242,767	3,256	3,256 $210,000

Others Institutions Holding ANIP

# of Institutions

202

Shares Held

15.5M

Call Options Held

24K

Put Options Held

7.7K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.02B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account